Boston, MA - NeuShen Therapeutics, a global biotech company focused on discovering and developing central nervous system (CNS) drugs, has announced the opening of its new Research and Development Center in Boston, Massachusetts. The facility boasts cutting-edge equipment and facilities for AAV-based gene therapy discovery, including a capsid engineering platform and disease treatment explorations. The center is designed to accommodate cross-functional teams and promote collaboration among academia and industry partners to create innovative solutions for CNS disorders.

The opening ceremony was attended by NeuShen's executives and scientists in Boston, scientific advisors, representatives from the biopharmaceutical industry, and local authorities. Dr. Joan Shen, Founder and CEO of NeuShen Therapeutics, led the ribbon-cutting ceremony and expressed her excitement about the new milestone in the company's global footprint. "The grand opening of our Boston R&D Center is a testament to our commitment to discovering and developing new gene therapies for CNS disorders," Dr. Shen said. "Our research center is founded on creativity and collaboration, and we are thrilled to enable our innovation to take flight." Other speakers at the ceremony included Dr. Mike Poole, founder and board member of NeuShen, Prof. Guangping Gao, scientific advisors and professor at the University of Massachusetts School of Medicine, and Ms. Sandhya Lyer, Director of economic development, Lexington township.

NeuShen Therapeutics' Boston R&D Center will be led by a team of professionals in the AAV-based gene therapy field and will form an open alliance with academia and industry partners. This collaboration will empower the ecosystem to share knowledge and build innovative solutions for CNS disorders.

About NeuShen

NeuShen Therapeutics is a biotechnology company focusing on innovative drug research and development to address central nervous system disorders, using a dual platform approaches including AAV-based gene therapy and small molecule discovery. With operations both in Shanghai, China and Boston, MA, NeuShen has a world-class team and is honored to be advised by an outstanding Board of Directors and Scientific Advisory Board.